According to, “Boston Scientific’s Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators – the leads in the heart.  The device that came to Boston Scientific through the Cameron Health acquisition in 2012 is inserted just under the skin near the chest. And on Monday the Marlborough, Massachusetts device maker announced that European Society of Cardiology is updating its guidelines that would allow physicians to use it in a certain group of patients. The hope is that the recommendation may boost Emblem-ICD’s adoption in Europe.”  Click here for more details: